With FDA and health system colleagues, I work on LLM methods to automate adverse event reporting for patient safety.
At MITRE I am technical leader for the largest US real-world evidence study of monoclonal antibodies for COVID-19, funded by ASPR.
The book explains AI, including topological data analysis and machine learning, with 23 case studies across healthcare.
I came to Dovetail as Chief Medical Officer to evaluate its clinical and analytic offerings, and it sold to Optum in December 2015.
I'm a Health AI leader at MITRE, and I co-authored Machine Intelligence for Healthcare at Ayasdi.
With FDA and health system colleagues, I work on LLM methods to automate adverse event reporting for patient safety.
At MITRE I am technical leader for the largest US real-world evidence study of monoclonal antibodies for COVID-19, funded by ASPR.
The book explains AI, including topological data analysis and machine learning, with 23 case studies across healthcare.
I came to Dovetail as Chief Medical Officer to evaluate its clinical and analytic offerings, and it sold to Optum in December 2015.
I'm a Health AI leader at MITRE, and I co-authored Machine Intelligence for Healthcare at Ayasdi.
With FDA and health system colleagues, I work on LLM methods to automate adverse event reporting for patient safety.
At MITRE I am technical leader for the largest US real-world evidence study of monoclonal antibodies for COVID-19, funded by ASPR.
The book explains AI, including topological data analysis and machine learning, with 23 case studies across healthcare.
I came to Dovetail as Chief Medical Officer to evaluate its clinical and analytic offerings, and it sold to Optum in December 2015.
By using this service, you agree to the Terms of Service and Privacy Policy.